Senti Biosciences, Inc. (SNTI)

NASDAQ: SNTI · IEX Real-Time Price · USD

0.369

-0.011 (-2.97%)

At close: May 2, 2024, 4:00 PM

0.357

-0.011 (-3.06%)

After-hours: May 2, 2024, 7:59 PM EDT

Senti Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-71.06	-58.21	-55.32	-19.86
Depreciation & Amortization	5.43	3.92	3.01	1.99
Share-Based Compensation	9.67	16.39	2.3	0.27
Other Operating Activities	3.56	3	15.38	-6.57
Operating Cash Flow	-52.4	-34.9	-34.64	-24.17
Capital Expenditures	-11.93	-41.37	-5.54	-1.16
Change in Investments	42.01	-40.59	0	12.52
Investing Cash Flow	30.08	-81.96	-5.54	11.36
Share Issuance / Repurchase	0.89	113.38	1.48	0.33
Debt Issued / Paid	-0.11	5.18	0	0
Other Financing Activities	-	-	66.95	37.72
Financing Cash Flow	0.78	118.55	68.44	38.05
Net Cash Flow	-21.54	1.7	28.26	25.24
Free Cash Flow	-64.33	-76.27	-40.18	-25.33
Free Cash Flow Margin	-2511.83%	-1779.51%	-1455.20%	-4475.97%
Free Cash Flow Per Share	-1.45	-2.92	-13.80	-1.83

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).